Month: August 2022

Kashiv Biosciences Receives Approval for Its First Biosimilar RELEUKO (filgrastim-ayow)

First of two biosimilars developed in collaboration with Amneal Pharmaceuticals Kashiv Biosciences Receives Approval for Its First Biosimilar RELEUKOTM (filgrastim-ayow) Know More